BioSpace News Archive

Vazyme, China’s leading biotechnology company, has recently released its 2021 annual report, revealing that the company has maintained a steady and solid growth throughout the past year.

Cullinan Oncology, Inc. announced that the compensation committee of the Company’s Board of Directors granted stock option awards to purchase an aggregate of 174,000 shares of its common stock to four employees outside Cullinan Oncology, Inc’s 2021 Stock Option and Incentive Plan.

Shionogi Inc., the United States subsidiary of Shionogi & Co., Ltd. based in New Jersey, has announced a strategic executive leadership re-organization and expansion of the company’s Executive Committee with the following changes effective July 1, 2022:.

via NewMediaWire – BioLife Sciences Inc., announced that it has filed Form 1-A with the Securities and Exchange Commission seeking to raise up to $20 million under a Tier I Regulation A+ offering.

Accutar Biotechnology, Inc., today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AC0176 for the treatment of patients with metastatic castration resistant prostate cancer (mCRPC) with disease progression on or after treatment with androgen receptor signaling inhibitors

Concert Pharmaceuticals, Inc. announced the pricing of an underwritten public offering of 10,000,000 shares of its common stock at a public offering price of $4.75 per share.

CANbridge Pharmaceuticals Inc. announced that it will participate in and present at the Jefferies Global Healthcare Conference 2022 on Friday, June 10, 2022 at 12:45 PM ET.

Micronutrient deficiencies disproportionately affect women and children in low- and middle-income countries.

Global Blood Therapeutics, Inc. announced that it will host a conference call and webcast for the investment community on Friday, June 10, 2022, at 3:00 p.m. CEST to discuss data on its sickle cell programs presented at the European Hematology Association Annual Congress and to provide business and R&D updates.

DICE Therapeutics, Inc. announced that management will present at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 2:30 p.m. ET.